Melqart Asset Management UK Ltd Grows Stake in Indivior PLC (NASDAQ:INDV)

Melqart Asset Management UK Ltd raised its position in shares of Indivior PLC (NASDAQ:INDV - Free Report) by 675.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 104,790 shares of the company's stock after acquiring an additional 91,280 shares during the period. Melqart Asset Management UK Ltd owned approximately 0.08% of Indivior worth $1,303,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in INDV. China Universal Asset Management Co. Ltd. purchased a new position in Indivior during the 4th quarter valued at $359,000. Stifel Financial Corp purchased a new stake in shares of Indivior during the third quarter valued at $100,000. Hennion & Walsh Asset Management Inc. bought a new position in shares of Indivior in the fourth quarter worth about $1,192,000. Geode Capital Management LLC increased its stake in Indivior by 7.7% in the 3rd quarter. Geode Capital Management LLC now owns 132,239 shares of the company's stock worth $1,289,000 after buying an additional 9,500 shares during the period. Finally, VELA Investment Management LLC lifted its holdings in Indivior by 45.5% during the 4th quarter. VELA Investment Management LLC now owns 179,659 shares of the company's stock valued at $2,264,000 after buying an additional 56,224 shares in the last quarter. Hedge funds and other institutional investors own 60.33% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently commented on INDV. Rodman & Renshaw started coverage on shares of Indivior in a research report on Tuesday, January 28th. They set a "buy" rating and a $16.00 target price on the stock. Piper Sandler reduced their price objective on Indivior from $16.00 to $13.00 and set an "overweight" rating on the stock in a report on Thursday, March 6th. Finally, RODMAN&RENSHAW upgraded Indivior to a "strong-buy" rating in a report on Tuesday, January 28th.

Indivior Trading Up 3.6 %

Shares of INDV traded up $0.42 during mid-day trading on Friday, hitting $11.97. The company's stock had a trading volume of 508,549 shares, compared to its average volume of 977,388. The company's 50-day moving average is $9.68 and its 200-day moving average is $10.41. Indivior PLC has a 52-week low of $7.33 and a 52-week high of $18.59. The firm has a market capitalization of $1.65 billion, a price-to-earnings ratio of -34.29 and a beta of 0.93.

Indivior (NASDAQ:INDV - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.22 by $0.19. The company had revenue of $266.00 million during the quarter, compared to analyst estimates of $240.13 million. Indivior had a negative return on equity of 241.73% and a negative net margin of 3.96%. As a group, sell-side analysts predict that Indivior PLC will post 1.22 earnings per share for the current fiscal year.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.